Universal Ibogaine
303-595 Howe St V6C 2T5 Vancouver, BC, Canada

There is a solution to the opioid crisis. We are bringing it to the world. Microdose.Buzz/UI100 #Ibogaine #NewFreedom #UIMasterClass

Join us in a deep dive into all things #Ibogaine, a key tool in combatting the opioid crisis. Microdose.Buzz/UI100 #NewFreedom #UIMasterClass

REGISTER TODAY! Your complimentary ticket is available only while quantities last! Click the link below to attend the virtual #Ibogaine Molecular Masterclass! #NewFreedom #UIMasterClass... microdose.buzz/UI100

Please join us as the Title Sponsor of the next Microdose MOLECULAR MASTERCLASS: The Ibogaine Conference taking place between February 19-20. This event will focus on Ibogaine and its analogues, the medicalization of Ibogaine and how capital markets come into play, how we should be reframing the addiction recovery paradigm. Interested in learning more? Register for the conference below

Join us and our wide array of international presenters including the most advanced authorities on psychedelic medical treatments! Claim your complimentary ticket in the link below to attend the virtual #Ibogaine Molecular Masterclass. #NewFreedom #UIMasterClass microdose.buzz/UI100

Congratulations

Join us today between 5:30-7:30 pm ET for the virtual Psychedelics & Sports event presented by Microdose. Hear from special guest NHL hockey legend Theo Fleury & a panel of his peers on pain med misuse in professional sport & potential plant medicine solutions. Get your tickets: https://bit.ly/32QeTMM #PsychedelicsAndSports

We are honored to have the opportunity to sponsor the Microdose "Psychedelics in Sports" event tomorrow Nov 18, 2020. We have a very special guest joining in as well. Please join us! Click here to learn more: https://bit.ly/32QeTMM #PsychedelicsAndSports #PlantMedicine

Psychedelic drugs are fueling a mental health revolution! Once deemed dangerous & illegal, #psychedelic compounds have been rediscovered by scientific & psychiatric communities as research reveals their capacity to help patients with a range of maladies.

Canada's Health Minister is calling on the Alberta Government to reconsider the closure of its injectable opioid agonist treatment program. If the three Alberta clinics that offer the treatment close, few people east of British Columbia would have access to the program, which is a cornerstone of the federal government's latest strategy to combat the opioid crisis.

The investigation of psychedelic drugs for their medical benefits is attracting investors. How does the leading US drug agency feel?

The shadow side of many elite contact sports, such as the NHL and the NFL, is encouraged and excessive use of opioid pain medication in order to ride through the inevitable injuries. There's a hidden epidemic of addiction among these athletes that is only now coming to light. Universal Ibogaine will be working with professional sports and player associations to raise awareness of the issue and provide information about ibogaine therapy as the only form of detox that is free from withdrawal symptoms in most cases.

Have you ever taken #LSD, #psilocybin, #mescaline or #ayahuasca? The survey’s purpose is to improve the understanding of the acute and longer-term effects of psychedelics. Then take part in the anonymous online survey!

Our global mission is to bring Ibogaine-based proven clinical treatment protocol to the world and help solve the global opioid crisis. Visit our website to learn about our approach: https://www.ibogaineinc.com

#Psychedelic Industry Continues To Draw Millions In Investments! MAPS recently raised $30 million as interest grows in the space.

Dissolvable oral strips dosed with psilocybin!? @CybinInc, a Canadian pharmaceutical development startup focused on #psychedelic drugs, went public on the NEO Exchange in Toronto on Monday Cybin’s stock jumped 23% during the first two days of trading.

#Mentalhealth care is ripe for innovation! In 2019 alone, venture capital companies invested a record-breaking $637 million in more than 60 different mental healthoriented companies, which is more than 22.8 times the investment in 2013.

Ibogaine has been used therapeutically for several indications, particularly detoxification from opiates. Read more about some of the potential medical benefits.

Our vision is to create the gold standard for addiction treatment with ibogaine-assisted psychotherapy. Take a look at our investor presentation to learn more about our work and upcoming milestones: https://bit.ly/3iJDyaA

Twice as many people now die of unintentional poisonings than traffic-related injuries. 2020 and the numbers continue to increase. What is the real crisis? #opioidcrisis

Ibogaine has been a subject of interest in the scientific community for decades. This 2019 research paper from Frontiers in Pharmacology investigates ibogaine's reported ability to reduce cravings and self administration of several highly addictive substances. Learn more about the findings: https://bit.ly/2ZL2yb5

Peter Thiel has backed a Berlin start-up, aiming to make #psychedelic drugs to treat #mentalhealth disorders in a $125 million funding round.

There have been 261 deaths in Alberta from #COVID in 2020 and 449 deaths from #opioid #overdose. Still think the #opioidepidemic is a hoax?

Opioid overdose is the number one cause of accidental death in North America for people under 50. There is a solution to the opioid crisis and we are working on bringing it to the world. Find out how by visiting our website: https://www.ibogaineinc.com/investors

#Opioid deaths skyrocket, mental #health suffers due to pandemic restrictions. The COVID-19 pandemic has wreaked havoc on Canadians suffering from mental illness, opioid #addiction and other substance abuse problems, says a new study released today by the Public Health Agency of Canada (PHAC) which confirms anecdotal reports warning that the pandemic's health consequences extend well beyond the novel coronavirus itself.

Learn more about our mission and what we are doing with #ibogaine to treat the roots of #addiction and end the #opioidepidemic. Go to ibogaineInc.com to receive this package!

The escalating opioid overdose crisis in North America is a multi-dimensional health challenge with complex causes and no clear-cut solution. As the International Journal of Drug Policy notes, the renaissance in psychedelic medicine comes at an opportune time, with clinical trials and research re-emerging to pinpoint alternative addiction interruption treatments. We are focused on the ibogaine aspect and are bringing clinical trials to Canada. ... More info here: https://bit.ly/33HTaWU

If Measure 109 passes on Tuesday, anyone in the state will soon be able to take a #therapeutic #psilocybin trip with a trained guide.

The present epidemic of opioid dependence justifies the consideration of novel therapeutic options, including the use of ibogaine. This research paper from The American Journal of Drug and Alcohol Abuse shines a light on ibogaine treatment and its reported association in reducing opioid use and the cessation of cravings. Have a read to learn more about this alternative form of treatment: https://bit.ly/3iF94Ye

A single seed planted, eventually becomes a garden in time - when things get tough, tend to the garden in your mind.

Vancouver-based Numinus has obtained a federal licence to test, sell, and distribute #psychedelic substances. B.C. researchers, advocates, and companies at forefront of Canada's psychedelic revolution

Universal Ibogaine's upcoming operation milestones include the following: Clinical trials applications submitted to Health Canada by end of 2020 TSX.V prospectus financing by end of 2020... Revenue producing clinics in operation early 2021 To learn more please visit: www.ibogaineinc.com

We are a Vancouver-based company with the goal of building a global network of addiction treatment clinics utilizing a proprietary Ibogaine assisted psychotherapy treatment protocol. Initial annual revenues per clinic are projected to be $3.7 million by 2022, rising up to$6.9 million per clinic in 2025 (at 70% occupancy). Learn more about our efforts and approach: www.ibogaineinc.com

As we progress with our clinical trials, our current plans are to have 2-3 clinics in operation by the end of 2021, expanding to at least 14 after 5 years. Visit our website to learn more about our ibogaine-assisted therapy approach: https://www.ibogaineinc.com

Revive, which has developed a psilocybin oral-thin film product, is planning a Phase 1 clinical study using the naturally derived drug to treat methamphetamine use disorder.

Health Canada has invited Universal Ibogaine to submit a clinical trials application for Phase 1 and Phase 2 of clinical trials which will be submitted by the end of Q4, 2020. We are also intending to submit a Phase 3 application by the end of 2021. Take a look at our vision: https://bit.ly/2ZQSKMK

Walmart has been sued by more than 2,000 states, cities and counties seeking to recoup billions in tax dollars spent battling the fallout from the #opioidcrisis.

Youth #hockey is one of the sports with players most at-risk for #opioid #addiction.

Since its formation in 2003, Clear Sky Recovery the operating clinic brand of Universal Ibogaine - has successfully disrupted opioid addiction using its proprietary ibogaine assisted psychotherapy treatment for over 3,500 patients. Check out their story: https://clearskyibogaine.com

The #Chicago location is the third @FieldTripHealth to open in the United States this year, providing an opportunity to continue normalizing the use of #psychedelics in healing across the country.

The treatment options currently available for addiction have very low long-term success rates. Ibogaine assisted psychotherapy has the potential to be a powerful healing medicine, allowing people to restart their lives. Watch how Universal Ibogaine is making this a reality.

The global psychedelics industry is expected to be worth over US$100 billion as attitudes towards psychedelics shift dramatically. Learn more about this burgeoning industry by reading Prohibition Partners' report.

The world has changed and these substances are being shined upon by a substantially-different light, says Rahn. MindMed, the New York-based company conducting clinical trials on #psychedelic drugs for #anxiety and #opioid use disorder, applied for an up-listing on the #Nasdaq.

In this Market One Minute, Shayne Nyquvest, Chairman of Universal Ibogaine, discusses his take on plant-based medicinal alternatives to addiction interruption. Watch the interview to learn more about his perspective.

Addiction can happen to anyone. Acknowledging His Son’s Addiction, Joe Biden Delivered the Most Human Moment at Last Night’s Debate. #PresidentialDebate2020 https://www.wellandgood.com/hunter-biden-addiction/

The new global psychedelics industry could be poised to save hundreds of billions annually on medication, counseling, and lost productivity entirely disrupting the way the world approaches mental healthcare. Learn more here: https://bit.ly/3iJBBeg

Universal Ibogaine is progressing through clinical trials applications in Canada to prove the safety and efficacy of ibogaine. At the same time, we will seek to open and acquire addiction treatment clinics in jurisdictions where ibogaine is recognized as legal. Get a better understanding of our mission: https://bit.ly/2ZQSKMK

Why now? The #opioidcrisis is deadly and growing. We’ve been invited by Health #Canada to submit a Clinical Trial Application, which will lead to #Ibogaine being licensed for use across Canada in a safe and #holistic treatment environment. Join us on our mission!

War #veterans with #PTSD, terminally ill patients and others suffering from #anxiety are backing a ballot measure that would legalize controlled, therapeutic use in #Oregon of #psilocybin #mushrooms.

We are a Vancouver based company with the goal of building a global network of addiction treatment clinics utilizing a proprietary Ibogaine assisted psychotherapy treatment protocol. Initial annual revenues per clinic are projected to be CAD$3.7 million by 2022, rising to up to CAD $6.9 million per clinic in 2025 (at 70% occupancy). Learn more about our efforts: www.ibogaineinc.com

Berkeley is launching the campus’s first center for #psychedelic #science and public #education. There's never been a better time to start a center like this!

Universal Ibogaine has finalized a corporate finance advisory service agreement with Westmount Park Investments to help develop and implement its go public transaction. Westmount's 50 years of experience and deep network of partners and affiliates have aided numerous private and public financings in industries from technology, real estate and healthcare. Learn more: https://bit.ly/358wH5N